Wieand HS - Search Results

1

Flow cytometric DNA analysis of stage I endometrial carcinoma.

Britton LC, Wilson TO, Gaffey TA, Lieber MM, Wieand HS, Podratz KC. Britton LC, et al. Among authors: wieand hs. Gynecol Oncol. 1989 Sep;34(3):317-22. doi: 10.1016/0090-8258(89)90165-0. Gynecol Oncol. 1989. PMID: 2767522

2

Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma.

Podratz KC, Malkasian GD Jr, Wieand HS, Cha SS, Lee RA, Stanhope CR, Williams TJ. Podratz KC, et al. Among authors: wieand hs. Gynecol Oncol. 1988 Mar;29(3):274-82. doi: 10.1016/0090-8258(88)90226-0. Gynecol Oncol. 1988. PMID: 3345949

3

Evaluation of treatment and survival after positive second-look laparotomy.

Podratz KC, Schray MF, Wieand HS, Edmonson JH, Jefferies JA, Long HJ, Malkasian GD, Stanhope CR, Wilson TO. Podratz KC, et al. Among authors: wieand hs. Gynecol Oncol. 1988 Sep;31(1):9-24. doi: 10.1016/0090-8258(88)90262-4. Gynecol Oncol. 1988. PMID: 3410358

4

Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.

Scott NA, Wieand HS, Moertel CG, Cha SS, Beart RW, Lieber MM. Scott NA, et al. Among authors: wieand hs. Arch Surg. 1987 Dec;122(12):1375-9. doi: 10.1001/archsurg.1987.01400240021002. Arch Surg. 1987. PMID: 3689111

5

DNA index by flow cytometric analysis: an additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation.

Zanetta G, Keeney GL, Cha SS, Wieand HS, Katzmann JA, Podratz KC. Zanetta G, et al. Among authors: wieand hs. Gynecol Oncol. 1996 Aug;62(2):208-12. doi: 10.1006/gyno.1996.0217. Gynecol Oncol. 1996. PMID: 8751551

6

Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival.

Zanetta G, Keeney GL, Cha SS, Farr GH Jr, Katzmann JA, Wieand HS, Edmonson JH, Podratz KC. Zanetta G, et al. Among authors: wieand hs. Am J Obstet Gynecol. 1996 Nov;175(5):1217-25. doi: 10.1016/s0002-9378(96)70031-5. Am J Obstet Gynecol. 1996. PMID: 8942491

7

Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival.

Hartmann LC, Sebo TJ, Kamel NA, Podratz KC, Cha SS, Wieand HS, Keeney GL, Roche PC. Hartmann LC, et al. Among authors: wieand hs. Gynecol Oncol. 1992 Nov;47(2):191-5. doi: 10.1016/0090-8258(92)90105-r. Gynecol Oncol. 1992. PMID: 1361479

8

Stage I ovarian epithelial carcinoma: survival analysis following definitive treatment.

Lentz SS, Cha SS, Wieand HS, Podratz KC. Lentz SS, et al. Among authors: wieand hs. Gynecol Oncol. 1991 Dec;43(3):198-202. doi: 10.1016/0090-8258(91)90019-2. Gynecol Oncol. 1991. PMID: 1752487

9

DNA ploidy in endometrial carcinoma: major objective prognostic factor.

Britton LC, Wilson TO, Gaffey TA, Cha SS, Wieand HS, Podratz KC. Britton LC, et al. Among authors: wieand hs. Mayo Clin Proc. 1990 May;65(5):643-50. doi: 10.1016/s0025-6196(12)65126-x. Mayo Clin Proc. 1990. PMID: 2348728

10

Effector function of lymphokine-activated killer cells and cytotoxic T lymphocytes in ovarian epithelial carcinoma.

Lentz SS, Kovach JS, McKean DJ, Wieand HS, Podratz KC. Lentz SS, et al. Among authors: wieand hs. Gynecol Oncol. 1990 Aug;38(2):191-6. doi: 10.1016/0090-8258(90)90039-n. Gynecol Oncol. 1990. PMID: 2387535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters